Published in Br J Clin Pharmacol on May 01, 1978
Patterns of drug taking in patients with chronic airflow obstruction. Postgrad Med J (1985) 0.99
Seatone in arthritis. Br Med J (Clin Res Ed) (1981) 0.75
A study of the placebo response. Am J Med (1954) 2.68
Editorial: Single daily dose of antidepressants. JAMA (1974) 1.95
Patient non-compliance within the context of seeking medical care for arthritis. J Chronic Dis (1973) 1.56
Placebos in the treatment of rheumatoid arthritis and other rheumatic conditions. Ann Rheum Dis (1957) 1.40
The evaluation of antirheumatic drugs. Curr Med Res Opin (1973) 1.26
Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol (1988) 35.68
Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med (1968) 27.34
Homoeopathic therapy in rheumatoid arthritis: evaluation by double-blind clinical therapeutic trial. Br J Clin Pharmacol (1980) 3.28
The MACTAR Patient Preference Disability Questionnaire--an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol (1987) 3.13
Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate. Br Med J (Clin Res Ed) (1983) 2.63
Occurrence of antibody to salivary duct epithelium in Sjogren's disease, rheumatoid arthritis, and other arthritides. A clinical and laboratory study. Ann Rheum Dis (1967) 2.43
Corticosteroid-induced suppression of the hypothalamo-pituitary-adrenal axis: observations on patients given oral corticosteroids for rheumatoid arthritis. Q J Med (1967) 2.38
Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs. Lancet (1991) 2.37
Measurement of joint inflammation. A radioisotopic method. Ann Rheum Dis (1970) 2.35
Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis. Ann Rheum Dis (1987) 2.29
Preference for endpoint measures in clinical trials: results of structured workshops. J Rheumatol (1983) 2.13
Sjogren's syndrome. I. Sicca components. Q J Med (1973) 2.08
An assessment of grip strength measurement in rheumatoid arthritis. Scand J Rheumatol (1974) 2.08
Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity. Ann Rheum Dis (1993) 2.05
Sjögren's syndrome and autoimmunity in a geriatric population. Age Ageing (1972) 2.01
Hypothesis: that rheumatoid arthritis will disappear. J Rheumatol (1979) 2.01
Judging "current disease activity" in rheumatoid arthritis--an international comparison. J Rheumatol (1983) 2.01
Illiteracy in rheumatoid arthritis patients as determined by the Rapid Estimate of Adult Literacy in Medicine (REALM) score. Rheumatology (Oxford) (2002) 2.00
Liver disease in Sjögren's syndrome and rheumatoid arthritis. Lancet (1970) 2.00
Method for assessing therapeutic potential of anti-inflammatory antirheumatic drugs in rheumatoid arthritis. Br Med J (1973) 1.97
Randomised controlled trials in general practice. Br J Gen Pract (2000) 1.94
Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis. Ann Rheum Dis (1997) 1.87
The maintenance of genetic polymorphism in small island populations: large mammals in the Hebrides. Philos Trans R Soc Lond B Biol Sci (1996) 1.85
A statistical aid to the diagnosis of keratoconjunctivitis sicca. Q J Med (1972) 1.81
Measurement of clinical response to anti-inflammatory drug therapy in rheumatoid arthritis. Q J Med (1973) 1.80
Sjogren's syndrome. 2. Clinical associations and immunological phenomena. Q J Med (1973) 1.77
Gastric studies in sjögren's syndrome. Gut (1966) 1.73
The use of radioisotopes in normal and diseased joints. Semin Arthritis Rheum (1972) 1.72
Scottish data on intrapartum related deaths are in same direction as Welsh data. BMJ (1998) 1.72
A preliminary evaluation of the dimensionality and clinical importance of pain and disability in osteoarthritis of the hip and knee. Clin Rheumatol (1986) 1.70
Does second-line therapy affect the radiological progression of rheumatoid arthritis? Ann Rheum Dis (1984) 1.69
Measurement of pain threshold in patients with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and healthy controls. Clin Rheumatol (1989) 1.69
Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol (1976) 1.69
Liver disease in rheumatoid arthritis and Sjøgren's syndrome. Prospective study using biochemical and serological markers of hepatic dysfunction. Ann Rheum Dis (1975) 1.66
Primary Sjögren's syndrome in north east England--a longitudinal study. Br J Rheumatol (1991) 1.64
Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology (Oxford) (2001) 1.63
Increased erythromycin resistance in clinical Campylobacter in Northern Ireland--an update. J Antimicrob Chemother (2005) 1.60
The articular scan in patients with rheumatoid arthritis: a possible method of quantitating joint inflammation using radio-technetium. Clin Sci (1968) 1.60
Salicylates and homoeopathy in rheumatoid arthritis: preliminary observations. Br J Clin Pharmacol (1978) 1.59
Derivation of knee joint synovial perfusion. Using the Xenon (133Xe) clearance technique. Ann Rheum Dis (1970) 1.59
Limitation of joint mobility and shoulder capsulitis in insulin- and non-insulin-dependent diabetes mellitus. Br J Rheumatol (1986) 1.59
Hypercalcaemia in rheumatoid arthritis: investigation of its causes and implications. Ann Rheum Dis (1979) 1.58
Nonsteroidal peptic damage in rheumatoid patients receiving second-line drugs. Am J Gastroenterol (1991) 1.57
Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years. Br Med J (Clin Res Ed) (1986) 1.55
Rapid identification of urinary tract infection bacteria using hyperspectral whole-organism fingerprinting and artificial neural networks. Microbiology (1998) 1.54
Evaluation of digital joint circumference measurements in rheumatoid arthritis. Scand J Rheumatol (1973) 1.54
Double blind randomized controlled trial of sodium meclofenamate (Meclomen) and diclofenac sodium (Voltaren): post validation reapplication of the WOMAC Osteoarthritis Index. J Rheumatol (1992) 1.53
HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA. Ann Rheum Dis (1992) 1.52
Depression in rheumatoid arthritis. J R Coll Gen Pract (1977) 1.52
Radiological manifestations in 200 patients with ankylosing spondylitis: correlation with clinical features and HLA B27. J Rheumatol (1979) 1.52
Which component of sulphasalazine is active in rheumatoid arthritis? Br Med J (Clin Res Ed) (1985) 1.51
A rheumatological dilemma: is it possible to modify the course of rheumatoid arthritis? Can we answer the question? Ann Rheum Dis (1985) 1.50
Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann Intern Med (1998) 1.50
Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis. Ann Rheum Dis (1985) 1.49
Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. Br J Psychiatry (2003) 1.48
Ibuprofen in rheumatoid arthritis. Clinical study of analgesic and anti-inflammatory activity. Ann Rheum Dis (1968) 1.47
Alteration of thiol and superoxide dismutase status in rheumatoid arthritis treated with sulphasalazine. Br J Rheumatol (1987) 1.45
Serum uric acid levels in normal pregnancy with observations on the renal excretion of urate in pregnancy. J Clin Pathol (1966) 1.43
Prior score availability: observations using the WOMAC osteoarthritis index. Br J Rheumatol (1991) 1.43
Evaluation of a functional index in rheumatoid arthritis. Scand J Rheumatol (1973) 1.42
Antineutrophil cytoplasmic antibody titres in patients with recent infection. Br J Rheumatol (1993) 1.42
A short review of the relationship between intestinal permeability and inflammatory joint disease. Clin Exp Rheumatol (1990) 1.42
Serum immunoreactive gastrin: specificity for rheumatoid arthritis, bimodality of distribution, and failure of effect of anti-inflammatory drugs. Ann Rheum Dis (1976) 1.42
The 'natural' history of active rheumatoid arthritis over 3-6 months--an analysis of patients enrolled into trials of potential disease-modifying anti-rheumatic drugs, and treated with placebo. Br J Rheumatol (1993) 1.42
Manubriosternal joint subluxation in rheumatoid arthritis. J Rheumatol (1983) 1.41
Rapid identification of Streptococcus and Enterococcus species using diffuse reflectance-absorbance Fourier transform infrared spectroscopy and artificial neural networks. FEMS Microbiol Lett (1996) 1.41
Immunological responses in Sjogren's syndrome and rheumatoid arthritis. Clin Exp Immunol (1971) 1.41
Serum sickness-like illness and leukocytoclastic vasculitis after intravenous streptokinase. J Am Acad Dermatol (1991) 1.40
A case of orbital myositis associated with rheumatoid arthritis. Ann Rheum Dis (2002) 1.40
Immunogenetics of polymyalgia rheumatica. Clin Exp Rheumatol (1994) 1.40
Methotrexate in rheumatoid arthritis. Impact on quality of life assessed by traditional standard-item and individualized patient preference health status questionnaires. Arch Intern Med (1990) 1.40
Are gallstones less prevalent in rheumatoid arthritis? Clin Rheumatol (1991) 1.39
Effect of Glyvenol (CIBA) on pain and on capillary resistance in rheumatoid arthritis. Ann Rheum Dis (1969) 1.39
Adverse effects of NSAIDs. Can Med Assoc J (1985) 1.39
Is diet important in rheumatoid arthritis? Br J Rheumatol (1991) 1.39
Predictive value of interleukin 1 gene polymorphisms for surgery. Ann Rheum Dis (2000) 1.38
Evidence based medicine: the median is not the message. J Rheumatol (2001) 1.38
Cot-nursing using a heated, water-filled mattress and incubator care: a randomized clinical trial. Acta Paediatr (2004) 1.38
Benefits of hospitalization in rheumatoid arthritis. Q J Med (1974) 1.37
Parasite interactions in natural populations: insights from longitudinal data. Parasitology (2008) 1.37
Abnormalities in mineral metabolism suggestive of parathyroid over-activity in rheumatoid arthritis. Curr Med Res Opin (1975) 1.36
The McMaster Health Index Questionnaire as a measure of quality of life for patients with rheumatoid disease. J Rheumatol (1983) 1.35
Reduction in haemoglobin after knee joint surgery. Ann Rheum Dis (1973) 1.34
The use of the Internet as a resource for health information among patients attending a rheumatology clinic. Rheumatology (Oxford) (2002) 1.33
Septic arthritis in patients with rheumatoid disease: a still underdiagnosed complication. J Rheumatol (1976) 1.31
Auranofin. Br J Rheumatol (1997) 1.30
Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy. Br J Rheumatol (1985) 1.30